It is Swedish Health Services' policy to provide IRB review of research activities involving human subjects, regardless of sponsorship, that are:
- Sponsored by or conducted within the components identified in Swedish Health Services' Federal Wide Assurance (FWA). Swedish Health Services' FWA number is "FWA00000544".
- Conducted by or under the direction of any employee or agent of the components identified under Swedish Health Services' FWA in connection with the employee or agent's institutional responsibilities, or
- Using the services of any of the components identified under Swedish Health Services' FWA , or
- Involving the use of Swedish Health Services' non-public information to identify or contact human research subjects for research.
Based on on items 1-4 above, if your study does qualify for review by a Swedish affiliated IRB, please click here.
If you have any questions about whether your study meets the above criteria for IRB review, please contact the Institutional Review Board office at (206) 215-2536 or by email at firstname.lastname@example.org. You may also call the Research Center administration office at (206) 215-3100.
The Swedish Research Center reserves the right to decline provision of IRB review of any research project.
Swedish Center for Research and Innovation
801 Broadway, Suite 725
Seattle, WA 98122-4328
Please note the recent publication by lead author Nameeta Shah, research scientist at The Ben and Catherine Ivy Center for Advanced Brain Tumor Treatment, Swedish Neuroscience Institute, Seattle WA, USA. The research article is: Exploration of the gene fusion landscape of glioblastoma using transcriptome sequencing and copy number data. Nameeta Shah, Michael Lankerovich, Hwahyung Lee, Jae-Geun Yoon, Brett Schroeder and Greg Foltz